Posts Tagged ‘apcer’
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.
Press Release (PharmiWeb)
8 Feb 2010APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.
Northwest Biotherapeutics, Inc., a development stage biotechnology company focused on personalized cancer vaccines to enhance immune system responses to tumors, has retained Market Media Connect as their communications agency of record. Led from its Los Angeles headquarters, Market Media Connect will support Northwest’s communication objectives as the company moves into the next phase of its …
About Biolexis
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.
Biotech
Categories
- Biotechnology News (1306)
Archives
- How to Train your Brain to keep you healthy and happy
- What makes you unique? Not genes so much as surrounding sequences, study finds
- How to Choose the Correct Workbenches For Your Organization’s Needs
- http://f-cup-products.blogspot.com/2010/03/puera-panic-sos-405mg-x-15-tablets-38.html
- A First: Microchips in living cells
- Enzyme Handbook: Volume 14: Class 2.7 – 2.8 Transferases EC 2.7.105 – EC 2.8.3.14
- Class 2 Transferases X: EC 2.7.1.113 – 2.7.5.7
- Seth Klarman’s Baupost Group Wins Big With Facet Biotech (FACT), Sells Some Shares
- The truth about health insurance profits
- Breaking down a three-tiered option play on the biotechnology concern (Schaeffers Research)
